Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/9761463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551182563803136 |
|---|---|
| author | Lei Qian Nanya Wang Huimin Tian Haofan Jin Hengjun Zhao Chao Niu Hua He Tingwen Ge Wei Han Jifan Hu Dan Li Fujun Han Jianting Xu Xiao Ding Jingtao Chen Wei Li Jiuwei Cui |
| author_facet | Lei Qian Nanya Wang Huimin Tian Haofan Jin Hengjun Zhao Chao Niu Hua He Tingwen Ge Wei Han Jifan Hu Dan Li Fujun Han Jianting Xu Xiao Ding Jingtao Chen Wei Li Jiuwei Cui |
| author_sort | Lei Qian |
| collection | DOAJ |
| format | Article |
| id | doaj-art-510d89e24bd64a3fa9d58e135277fd55 |
| institution | Kabale University |
| issn | 2314-7156 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-510d89e24bd64a3fa9d58e135277fd552025-02-03T06:04:49ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/9761463Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”Lei Qian0Nanya Wang1Huimin Tian2Haofan Jin3Hengjun Zhao4Chao Niu5Hua He6Tingwen Ge7Wei Han8Jifan Hu9Dan Li10Fujun Han11Jianting Xu12Xiao Ding13Jingtao Chen14Wei Li15Jiuwei Cui16Department of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterDepartment of Cancer CenterInstitute of Translational MedicineDepartment of Cancer CenterDepartment of Cancer Centerhttp://dx.doi.org/10.1155/2022/9761463 |
| spellingShingle | Lei Qian Nanya Wang Huimin Tian Haofan Jin Hengjun Zhao Chao Niu Hua He Tingwen Ge Wei Han Jifan Hu Dan Li Fujun Han Jianting Xu Xiao Ding Jingtao Chen Wei Li Jiuwei Cui Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” Journal of Immunology Research |
| title | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_full | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_fullStr | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_full_unstemmed | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_short | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_sort | corrigendum to dual effects of cellular immunotherapy in inhibition of virus replication and prolongation of survival in hcv positive hepatocellular carcinoma patients |
| url | http://dx.doi.org/10.1155/2022/9761463 |
| work_keys_str_mv | AT leiqian corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT nanyawang corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT huimintian corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT haofanjin corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT hengjunzhao corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT chaoniu corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT huahe corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT tingwenge corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT weihan corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT jifanhu corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT danli corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT fujunhan corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT jiantingxu corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT xiaoding corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT jingtaochen corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT weili corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT jiuweicui corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients |